Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters

Part of paid clinical trials in Wilmington, Delaware.

Sponsor
Summa Therapeutics, LLC
Study ID
NCT06906055
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Peripheral Arterial Disease Below the Knee
  • Peripheral Arterial Disease, Rutherford 4 and 5 with Possibility to Improve Vascularization

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

  • Multicath — DEVICE
    Use of a multifunctional catheter for revascularization of blocked arteries below the knee
  • Standard of Care (SOC) — DEVICE
    Use of single function crossing catheters, diagnostic catheters, angioplasty balloon catheters

Study Details

Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters ("BTK Multicath Registry") A non-randomized clinical registry This study is designed to obtain preliminary data on clinically relevant procedural variables during percutaneous below-knee artery revascularization procedures among consecutive patients treated with either the Finesse BTK Multicath® ("Finesse") or the standard of care using conventional angioplasty balloon catheters. This registry will enroll participants with a history of chronic limb threatening ischemia and below-knee arterial insufficiency who will be assigned to revascularization with or without use of the Finesse BTK Multicath. The registry is an acute study examining procedural data only. The primary endpoints of interest are the volume of contrast used for the intervention, overall procedure time, radiation dose, number of catheter exchanges during revascularization, and medical device supply costs. For the first phase 12 consecutive patients will be treated with the standard of care. For the second phase 12 consecutive patients will be treated with Finesse. 24 participants total Up to 5 study sites in the United States Initial anticipated enrollment: Q4 2024 Last anticipated enrollment: Q2 2025 Patients \>=18 years old with documented history of unilateral chronic limb threatening ischemia due to below-knee arterial insufficiency with angiographic runoff in the foot and limited arterial insufficiency above the knee 1. Contrast volume administered during the revascularization portion of a procedure. 2. Number of catheter exchanges during revascularization 3. Fluoroscopy time 4. Radiation dose during revascularization 5. Procedure time post-enrollment 6. Equipment costs 7. Reduced use of supplies 8. Technical success 9. Safety/Major Adverse Peripheral Events On-treatment sample Intention-to-treat

Key Dates

Start date
Apr 3, 2025
Status verified
Mar 2025
Primary completion
Dec 31, 2025
Completion
Jun 30, 2026

Study Design

Enrollment
24 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Standard of care
    Use of conventional single function crossing catheters, diagnostic catheters, angioplasty balloon catheters
  • Experimental: Finesse BTK Multicath
    Use of a multifunctional revascularization catheter

Primary Outcome Measure

Contrast volume [ Time Frame: during the intervention/procedure/surgery ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Endovascular ConsultantsWilmingtonDelaware19805
Laurie Francoeur
8772672685
Atlantic Medical ImagingVinelandNew Jersey08360
Laurie Francoeur
8772672685

Find similar trials in Wilmington, DE